Philip O. Katz MD, MACG, AGAFProfessor of Medicine and Director of the GI Function Laboratories, Division of Gastroenterology and Hepatology, Weill Cornell Medicine, New York, New York
Philip O. Katz, MD, is Professor of Medicine and Director of the GI Function Laboratories in the Division of Gastroenterology and Hepatology at Weill Cornell Medicine in New York City. Dr. Katz received his medical degree from the Bowman Gray School of Medicine at Wake Forest University in Winston-Salem, North Carolina. He served his residency and chief residency in internal medicine, followed by a fellowship in gastroenterology at the Bowman Gray School of Medicine. He completed a faculty development fellowship at Johns Hopkins University in Baltimore, Maryland. He is board certified in internal medicine and gastroenterology. Dr. Katz is a Past President of the American College of Gastroenterology (ACG) (2009-2010) and is a member of the American Gastroenterological Association and the American Society for Gastrointestinal Endoscopy. He was the founding editor of the American College of Gastroenterology Universe, the on line learning portal of that organization. He was awarded the J Stanley Cohen Award for research excellence by Einstein Medical Center (Philadelphia) in 2012 and Berk-Fise Clinical Achievement Award by the ACG in 2014. A recognized national authority on esophageal disease, Dr. Katz’s research interests include all aspects of gastroesophageal reflux disease, including nocturnal recovery of gastric acid secretion during proton pump inhibitor therapy and esophageal pain perception. Dr. Katz is a practicing clinician with active teaching and editorial positions. In addition to lecturing on many gastroenterology-related topics, Dr. Katz served as an associate editor of the American Journal of Gastroenterology and is an editorial reviewer for Annals of Internal Medicine, Gastroenterology American Journal of Gastroenterology, Gastroenterology, Clinical Gastroenterology and Hepatology and Alimentary Pharmacology and Therapeutics. He has contributed to the publication of over 190 peer-reviewed papers, as well as numerous abstracts, books, book chapters, and monographs.
Dr. Katz reports no relevant disclosures.
Recent Contributions to PracticeUpdate:
- High- vs Low-Dose Swallowed Topical Steroids for Maintenance Treatment of EoE
- Proton Pump Inhibitor All-Cause and Cause-Specific Mortality in US Veterans
- PPIs Not Associated With Changes in Bone Strength and Structure
- Diagnosis of Esophageal Motility Disorders
- MY APPROACH to GERD Symptoms Refractory to PPI Therapy
- Transoral Fundoplication Eliminates GERD Symptoms